The biotechnology recovery is not a farce. These 3 stocks could lead the next bullish leg
The stock market's attention has been focused almost exclusively on artificial intelligence, semiconductors and a handful of large-cap technology companies.…
Breaking News: Markets
Cramer Says This Stock Is Significantly Undervalued And Sees 35% Upside
Every weekday, CNBC's Investment Club with Jim Cramer hosts a livestream “morning meeting” at 10:20 a.m. ET. Here's a recap…
Rivian Shares Fall 12% Amid Plans to Sell 75 Million Shares
A motherboard from one of Rivian's all-electric vehicles. Michael Wayland/CNBC Rivian Automotive Shares plunged nearly 15% in midday trading Tuesday…
Abivax shares soar after new data on drugs for intestinal diseases
Shares of a French biotechnology company Abivax surged on Tuesday after it released new data on its lead drug for…
This life sciences stock has a secret weapon and AI will only make it more valuable
IQVIA, with its vast trove of health information, is at the center of drug development, providing data, tools and services…
Abivax Shares Plunge Amid Cancer Cases in Bowel Disease Drug Trial
Actions of Abivax It closed down 43.6% on Tuesday after reporting new data on its top asset, an ulcerative colitis…
The group led by JPMorgan Chase controls credit
The JPMorgan Chase & Co. building before the groundbreaking ceremony, at the company's new headquarters at 270 Park Avenue, in…
McDonald's (MCD) earnings in the first quarter of 2026
McDonald's on Thursday reported quarterly earnings and revenue that beat analysts' expectations as diners spend more at its U.S. restaurants…
Eli Lilly Stock Rising Rapidly, Proving Stock Plunge Was a Mistake
Obesity drug giant Eli Lilly reported a monster first quarter on Thursday, strengthening our conviction to hold the stock after…
The liquidation of Cardinal Health was an overreaction. we would be buyers
We've taken a closer look at Cardinal Health's quarterly results and Thursday's post-settlement conference call. Our conclusion: The 4.9% drop…